<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04712513</url>
  </required_header>
  <id_info>
    <org_study_id>12052020</org_study_id>
    <nct_id>NCT04712513</nct_id>
  </id_info>
  <brief_title>Dynamic CT Perfusion for Functional Assessment of Coronary Artery Disease</brief_title>
  <official_title>Multicenter Diagnostic Performance of Dynamic CT Perfusion for Functional Assessment of Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this multicenter study is to evaluate the diagnostic accuracy of dynamic&#xD;
      cardiac CT perfusion (CTP) imaging for non-invasive functional assessment of coronary artery&#xD;
      disease (CAD). The proposed CTP technique allows concomitant assessment of two&#xD;
      imaging-derived cardiac biomarkers including fractional flow reserve (FFR) and myocardial&#xD;
      perfusion from a single dynamic imaging sequence, which facilities simultaneous evaluation of&#xD;
      the hemodynamics in epicardial coronary arteries and coronary microcirculation in patients&#xD;
      with CAD. The CTP results will be compared with invasive coronary angiography / FFR&#xD;
      assessment and non-invasive cardiac magnetic resonance imaging (CMR) / radionuclide perfusion&#xD;
      assessment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Accuracy of myocardial perfusion obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosis</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Comparison with invasive coronary angiography and FFR assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of FFR obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosis</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Comparison with invasive coronary angiography and FFR assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of combined myocardial perfusion and FFR measurement obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosis</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Comparison with invasive coronary angiography and FFR assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and static CT perfusion</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Comparison in patients with multi-vessel CAD where balanced ischemia is expected</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and CT-FFR (based on computational fluid dynamics simulation)</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Comparison in patients with dense coronary calcification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and other non-CT perfusion imaging techniques</measure>
    <time_frame>Within 4 weeks of the acquisition of non-CT perfusion imaging</time_frame>
    <description>Comparison with CMR / radionuclide perfusion assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of diagnostic accuracy of dynamic CT perfusion for functional CAD assessment between male and female patients</measure>
    <time_frame>Within 4 weeks prior to invasive cardiac catheterization</time_frame>
    <description>Sex-based analysis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Patients with coronary artery disease and hemodynamically stable</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dynamic cardiac CT perfusion imaging</intervention_name>
    <description>Multiple images of the heart are acquired with a clinical CT scanner after an intravenous bolus injection of contrast solution. The images are then analyzed to provide fractional flow reserve and myocardial perfusion values.</description>
    <arm_group_label>Patients with coronary artery disease and hemodynamically stable</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible patients are those who have clinically indicated referral for cardiac&#xD;
        catheterization based on clinical history and sign of ischemia or obstructive coronary&#xD;
        lesion(s) from non-invasive imaging test (radionuclide myocardial perfusion imaging, CMR&#xD;
        myocardial perfusion imaging, or CCTA).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        1. Subject Inclusion Criteria&#xD;
&#xD;
             Patients need to meet all the following inclusion criteria to be enrolled in the&#xD;
             study:&#xD;
&#xD;
               1. Symptomatic and hemodynamically stable&#xD;
&#xD;
               2. Acute coronary syndrome (ACS) ruled out based on absence of abnormal changes in&#xD;
                  ECG and cardiac enzymes&#xD;
&#xD;
               3. Referral for cardiac catheterization based on clinical history and non-invasive&#xD;
                  imaging test findings. Non-invasive imaging findings include one or more of the&#xD;
                  following: (i) Evidence of myocardial ischemia from radionuclide myocardial&#xD;
                  perfusion imaging; (ii) Evidence of myocardial ischemia from CMR myocardial&#xD;
                  perfusion imaging; (iii) Evidence of ≥ 50% stenosis in the left circumflex artery&#xD;
                  (LCx), left anterior descending artery (LAD) and/or right coronary artery (RCA)&#xD;
                  from CCTA.&#xD;
&#xD;
               4. Ability to undergo stress myocardial perfusion test (absence of contraindications&#xD;
                  for vasodilator)&#xD;
&#xD;
               5. Written informed consent&#xD;
&#xD;
          2. Subject Exclusion Criteria&#xD;
&#xD;
        Patients meeting at least one of the following criteria will be excluded from the study:&#xD;
&#xD;
          1. Recent (&lt; 1 month) ACS&#xD;
&#xD;
          2. CCTA reveals ≥ 50% stenosis in the left main artery&#xD;
&#xD;
          3. Severe chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) &lt;&#xD;
             30 mL/min/1.73m2&#xD;
&#xD;
          4. Contraindications to stress perfusion imaging, including: i) severe reactive airway&#xD;
             disease; ii) high-grade atrioventricular block; iii) allergy to vasodilators; iv)&#xD;
             caffeine within 12 hours; v) theophylline use within 48 hours.&#xD;
&#xD;
          5. History of CABG surgery&#xD;
&#xD;
          6. History of malignancy during the past 3 years prior to screening&#xD;
&#xD;
          7. History of alcohol and/or drug abuse within 3 years prior to screening&#xD;
&#xD;
          8. Sign of pregnancy&#xD;
&#xD;
          9. Pregnant or nursing&#xD;
&#xD;
         10. History of severe allergic or anaphylactic reaction to any allergen including drugs&#xD;
             and contrast agents&#xD;
&#xD;
         11. Recent (&lt; 1 month) use of an investigational drug or device&#xD;
&#xD;
         12. Participation in any other investigational drug or device trial during the conduct of&#xD;
             this study&#xD;
&#xD;
         13. Lack of ability or willingness to comply with the protocol requirements or deemed by&#xD;
             the Site Investigator to be unfit for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aaron So, PhD</last_name>
    <phone>(519)9315777</phone>
    <phone_ext>24224</phone_ext>
    <email>aso@robarts.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Joseph's Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Aaron So, PhD</last_name>
      <phone>(519)9315777</phone>
      <phone_ext>24224</phone_ext>
      <email>aso@robarts.ca</email>
    </contact>
    <investigator>
      <last_name>Aaron So, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Teefy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shahar Lavi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Aaron So</investigator_full_name>
    <investigator_title>Scientist</investigator_title>
  </responsible_party>
  <keyword>Computed Tomography</keyword>
  <keyword>Myocardial Perfusion</keyword>
  <keyword>Fractional Flow Reserve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

